| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Mamu-A*08 & B2M | Biotinylated Rhesus macaque Mamu-A*08&B2M Monomer Protein (Peptide free, MALS verified) |  Rhesus macaque | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Pozetaldogene ormesparvovec | SBT-101 | Phase 2 Clinical | SwanBio Therapeutics Ltd | Adrenoleukodystrophy | Details |
| TYF-ABCD1 | TYF-ABCD1 | Clinical | Shenzhen Geno-Immune Medical Institute | Adrenoleukodystrophy | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Elivaldogene autotemcel | Approved | Bluebird Bio Inc, Inserm | Lenti-D, Skysona | United States | Adrenoleukodystrophy | Bluebird Bio Inc | 2021-07-27 | Adrenoleukodystrophy | Details |
